IECM
TMDX icon

Intrinsic Edge Capital Management’s Transmedics TMDX Stock Holding History

Intrinsic Edge Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,000
Closed -$1.51M – 213
2023
Q1 		$1.51M Buy
+20,000
New +$1.38M 0.15% 120
2020
Q3 		– Sell
-150,000
Closed -$2.69M – 291
2020
Q2 		$2.69M Buy
+150,000
New +$2.35M 0.25% 149

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Intrinsic Edge Capital Management's TMDX Position: Q2 2023 in Review

Intrinsic Edge Capital Management sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 20,000 shares — an estimated $1.51M sold.

Intrinsic Edge Capital Management first reported a position in TMDX in Q2 2020 and held it in 2 quarters. The position peaked at $2.69M in Q2 2020. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

  • Intrinsic Edge Capital Management reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 20,000 Transmedics shares in Q2 2023, an estimated $1.51M.
  • Intrinsic Edge Capital Management first reported a position in Transmedics in Q2 2020 and held it in 2 quarters.
  • Intrinsic Edge Capital Management's Transmedics position peaked at $2.69M in Q2 2020.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.